Pregled bibliografske jedinice broj: 1007277
Present and new vaccines for human use
Present and new vaccines for human use // 2nd Croatian Congress of Food Technologists, Biotechnologists and Nutritionists : proceedings ; u: Prehrambeno-tehnološka i biotehnološka revija 32 (2/3)
Zagreb, 1994. str. 107-109 (predavanje, domaća recenzija, cjeloviti rad (in extenso), znanstveni)
CROSBI ID: 1007277 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Present and new vaccines for human use
Autori
Silobrčić, Vlatko
Vrsta, podvrsta i kategorija rada
Radovi u zbornicima skupova, cjeloviti rad (in extenso), znanstveni
Izvornik
2nd Croatian Congress of Food Technologists, Biotechnologists and Nutritionists : proceedings ; u: Prehrambeno-tehnološka i biotehnološka revija 32 (2/3)
/ - Zagreb, 1994, 107-109
Skup
Croatian Congress of Food Technologists, Biotechnologists and Nutritionists (2 ; 1994)
Mjesto i datum
Zagreb, Hrvatska, 15.06.1994. - 19.06.1994
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
xxx
Sažetak
Vaccination is the least expensive and most effective medical procedure. Durin the last 29 years, the percentage of vaccined childern has risen from 5 to 80 ant this resulted in a 50 % reduction of morbidity and mortality rate from childern' infectious diseases. Vaccines against measles, tetnus, pertussis, diphtheria, tuberculosis and poliomyelitis have been most importal in echieving this result. These vaccines are veryeffective, with side effects of acceptable incidence and severity. Yet, their improvement is desirable, to make them more thermostabile (long-tasting transport), contain more immunogens (multiple protection with single application), appčlicable oraly and as soon after birth aspossible (early protection). Research on vaccines for application to human (both childern and adults) is directef towardimprovement of existing vaccinesand introduction of new ones. Because of these two goals, new technologiesvfor preparation and application, newimmunoadjuvants and new vaccines against: viruses, cancer, autoimmune diseases, parasites and AIDS are investigated. As an example, research in these fields is described ; protein carriers of vaccinal immunogens (synthetc, proteosomes, recombinant BCG), immunoadjuvants (nonionic polymers, saponins, monoclonal antibiotics), and new ways of vaccine application (microencapsulatiov, attenuated viruses). It is concludedthat new technologies provide apportinities for completely new approashes to peparation and administration of vaccines, at the same time enabling discoveries of new basic concepts of functioning of the immune system in men.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
